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ABSTRACT: Red blood cells (RBCs) are the most abundant
cell type in the human body. RBCs and, in particular, their
plasma membrane composition have been extensively studied
for many years. During the past decade proteomics studies
have extended our knowledge on RBC composition; however,
these studies did not provide quantitative insights. Here we
report a large-scale proteomics investigation of RBCs and their
“white ghost” membrane fraction. Samples were processed
using the multienzyme digestion filter-aided sample prepara-
tion (MED-FASP) and analyzed using Q-Exactive mass
spectrometer. Protein abundances were computed using the
total protein approach (TPA). The validation of the data with stable isotope-labeled peptide-based protein quantification
followed. Our in-depth analysis resulted in the identification of 2650 proteins, of which 1890 occurred at more than 100 copies
per cell. We quantified 41 membrane transporter proteins spanning an abundance range of five orders of magnitude. Some of
these, including the drug transporter ABCA7 and choline transporters SLC44A1 and SLC44A2, have not previously been
identified in RBC membranes. Comparison of protein copy numbers assessed by proteomics showed a good correlation with
literature data; however, abundances of several proteins were not consistent with the classical references. Because we validated
our findings by a targeted analysis using labeled standards, our data suggest that some older reference data from a variety of
biochemical approaches are inaccurate. Our study provides the first “in-depth” quantitative analysis of the RBC proteome and
will promote future studies of erythrocyte structure, functions, and disease.
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■ INTRODUCTION
Red blood cells (RBCs) are the most abundant human blood
cells. Apart from their pivotal role in oxygen and carbon dioxide
transport, RBCs are involved in the transfer of glycophospha-
tidylinositol-linked protein immune complexes.1 The plasma
membrane of the RBCs is mechanically supported by spectrin
tetramers connected by actin junctional complexes, forming a
2D six-fold triangular network anchored to the lipid bilayer.2
To date, the membrane protein composition and structure has
been investigated by chemical staining,3,4 immunoassay
methods,5−7 crystallography,8 scanning electron microscopy,
and atomic force microscopy.9
In contrast with the conventional biochemical approaches
targeting single or few proteins, large-scale proteomics enables
insights into thousands of proteins in a single experiment,
including their abundances. However, all early proteomics
analyses of RBCs failed to provide comprehensive data sets.
The reasons were the presence of hemoglobin interfering with
identification of lower abundant proteins and the limitations of
proteomics technology to analyze membrane proteins. Further
progress in analysis of cytosolic fraction of RBCs was possible
using extensive fractionation of proteins10,11 and by reduction
of hemoglobin content using peptide libraries.12 Depletion of
hemoglobin by metal affinity chromatography13 allowed
reproducible measuring and relative quantification of over
1000 proteins across cytosolic preparations from a series of
RBCs donors.14 Using the N-terminomics procedure, Overall et
al. identified 1369 human erythrocyte proteins.15 Analysis of
the membrane preparation of RBCs from Diamond−Blackfan
anemia patients, using extensive gel fractionation, allowed the
identification of >1100 mainly nonmembrane proteins.16
Applying diverse depletion strategies to a triton insoluble
membrane skeleton fraction enabled semiquantitative profiling
of 77 proteins.17
Despite its potential, so far proteomics has not provided a
comprehensive and quantitative picture of the erythrocyte. We
aimed to (1) perform an in-depth proteomics analysis of whole
RBCs and their “white ghost” (WG) preparations and to (2)
quantify proteins in whole cells and their membrane fraction,
including low abundance membrane transporters.
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■ MATERIALS AND METHODS
Erythrocytes
Blood samples were provided by the authors and further
laboratory employees who gave their informed consent. Nine
mL of fasting venous blood was collected with minimal stasis
into EDTA tubes. The procedure was modified from previously
published methods16 (Figure 1). To minimize proteolysis, all
samples and buffers were kept at 0−4 °C during all steps. RBCs
were collected from the plasma by centrifugation for 5 min at
150g and were suspended in PBS containing 1 mM EDTA.
Then, the slurry was passed through a leucocyte depletion filter
(Acrodisc, PSF Syringe Filters, Pall, Ann Arbor, MI). RBCs
were washed four times with PBS and stored overnight on ice
at 4 °C in PBS containing 10 mM glucose and EDTA-free
protease inhibitor cocktail tablets (Roche, Mannheim,
Germany).
Preparation of “White Ghosts”
WGs were isolated according to Pesciotta et al.14 In brief, the
purified RBCs were lysed using 10 volumes of hypotonic lysis
buffer composed of 5 mM sodium phosphate, 1 mM EDTA,
complete, mini EDTA-free protease inhibitor cocktail, pH 8.0;
the WGs were then isolated by centrifugation at 21 000g for 40
min. WG were purified by four to five additional washes and
centrifugations.
Lysis of the Cells and Membrane Preparations
Whole RBCs and WGs were lysed in 0.1 M Tris-HCl
containing 2% SDS and 0.05 M DTT at 100 °C for 5 min.
Protein and Peptide Determination
Total protein concentration in lysates and the peptide content
in the digests (see below) were assayed using a tryptophan
fluorescence-based WF assay in microtiter plate format.18 For
measurements, Corning Costar 96-well black flat-bottomed
polystyrene plates (Sigma-Aldrich, Taufkirchen) were used.
Multienzyme Digestion Filter-Aided Sample Preparation
(MED FASP)
Sample aliquots containing 100 μg total protein were processed
using the MED FASP method19 with modifications described
recently.20 Proteins were first cleaved overnight using
endoproteinase ArgC, GluC, or LysC, and in the second step
they were digested with trypsin for 2 h. The enzyme-to-protein
ration was 1:50. Digestions with LysC and trypsin were carried
out in 50 mM Tris-HCl, pH 8.5. For the cleavage with ArgC
the buffer was supplemented with 10 mM MgCl2. The
digestion with GluC was carried out in 25 mM ammonium
bicarbonate. All reactions were conducted at 37 °C. Aliquots
containing 10 μg total peptide were concentrated to a volume
of ∼5 μL and were stored frozen at −20 °C until mass
spectrometric analysis. Ten μg aliquots of the peptides were
deglycosylated with 4 units PNG-ase F at room temperature for
2 h.
Liquid Chromatography−Tandem Mass Spectrometry
Analysis of peptide mixtures was performed using a QExactive
HF mass spectrometer (Thermo-Fisher Scientific, Palo Alto).
Aliquots containing 5 μg total peptide were chromatographed
on a 50 cm column with 75 μm inner diameter packed C18
Figure 1. Overview of the analytical workflow. (A) Venous blood was collected form four healthy donors. Erythrocytes were collected by
centrifugation and remaining leucocytes were depleted by filtration. We used purified erythrocytes for isolation of membrane fraction, so called the
“White Ghosts”. (B) The purified cells and the membrane fractions were lysed in buffer containing 2% SDS, and the protein extracts were processed
using the MED FASP method. Each sample was successively digested using endoproteinase ArgC and trypsin, endoproteinase GluC and trypsin, and
endoproteinase LysC and trypsin. (C) The isolated peptides were chromatographed on a C18 column coupled to mass spectrometer. The mass
spectra were searched using MaxQuant software. Proteins were quantified using the “Total Protein Approach”.
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material (100 Å pore size; Dr. Maisch, Ammerbuch-Entringen,
Germany). Peptide separation was carried out at 300 nL/min
for 75 min using a two-step acetonitrile gradient 5−40% over
the first 60 min and 40−95% for the following 15 min. The
backpressure varied between 450 and 650 bar. The temperature
of the column oven was 55 °C.
The mass spectrometer operated in data-dependent mode
with survey scans acquired at a resolution of 50 000 at m/z 400
(transient time 256 ms). Up to the top 15 most abundant
isotope patterns with charge ≥ +2 from the survey scan (300−
1650 m/z) were selected with an isolation window of 1.6 m/z
and fragmented by HCD with normalized collision energies of
25. The maximum ion injection times for the survey scan and
the MS/MS scans were 20 and 60 ms, respectively. The ion
target value for MS1 and MS2 scan modes was set to 3 × 106
and 3 × 105, respectively. The dynamic exclusion was 25 s and
10 ppm. The mass spectrometry data have been deposited to
the ProteomeXchange Consortium via the PRIDE partner
repository21 with the data set identifier: PXD005200.
Stable Isotope-Labeled Peptide-Based Protein
Quantification
Peptides with isotopically labeled lysine (13C6, 15N2) and
arginine (13C6, 15N4) residues were purchase from (Sigma-
Aldrich). The peptide matching sequences of erythrocyte band
7 integral membrane protein/stomatin (SLC4A1/STOM)
(TISFDIPPQEILTK, YLQTLTTIAAEK), glycophorin A
(GYPA) (TVYPPEEETGER), and glucose transporter 1/solute
carrier family 2 member A (GLUT1/SLC2A1) (TFDEIAS-
GFR) were selected on the basis of the proteomics analysis
using the LysC and trypsin digestion. The selected peptides
were repeatedly identified in the analyses of the WG
preparations. Ten μg aliquots of the digest of the WG lysate
were spiked with 0.5, 1, 2, or 5 pmol of the labeled peptides and
were LC−MS/MS analyzed as described above. Ratios of heavy
to light MS1 intensities of “light” and “heavy” (standard)
peptides were manually extracted from the spectra (Xcalibur
Qual Browser) and used for calculation of concentrations of
targeted proteins (Table S1).
Figure 2. Peptide and protein identification and quantification in lysates of whole erythrocytes (red−pink colors) and their white ghosts (blue−
purple colors). (A,B) Identification of peptides obtained by three different cleavage approaches using either ArgC followed by trypsin, GluC followed
by trypsin, LysC followed by trypsin. In each group the first, second, third, and fourth bars indicate number of peptides identified from the digest
with the first enzyme and the second enzyme (in all trypsin), the composite number of peptides from both digestions, and the total number of
peptides from both digestions using the “matching between runs” algorithm of the MaxQuant software. (C−E) Cumulative number of proteins
sorted by the number of matching peptides from individual digestion approaches. (F) Cumulative number of proteins sorted by the number of
matching peptides from all approaches. (G,H) Venn plots with the number of identified proteins using various digestion approaches.
Journal of Proteome Research Article
DOI: 10.1021/acs.jproteome.7b00025
J. Proteome Res. 2017, 16, 2752−2761
2754
Data Analysis
The spectra were searched using MaxQuant software. All raw
files were searched together in single MaxQuant run using
separate parameter options for MS files from analyses of Arg C,
LysC, GluC, and tryptic peptides. For the tryptic peptides
generated from the GluC-precleaved material a mixed GluC/
tryptic specificity was set. A maximum of two missed cleavages
was allowed. Carbamidomethylation was set as fixed
modification. The “matching between the runs” option was
used. The maximum false peptide and protein discovery rate
was specified as 0.01. Protein abundances were calculated using
the “total protein approach” (TPA) method.22 The calculations
were performed in Microsoft Excel.
The copy number of protein was calculated using the
relationship

















and NA is the Avogadro number.
We assumed the mean volume of RBCs of 90 fL23 and the
average total protein content per cell as 20% of RBCs mass.24
The values obtained using different proteinase were averaged.
Calculation of copy numbers using data from the analysis of
the WG fractions (Copy numberWG) was performed using the
membrane protein enrichment (MPE) factor. This factor
reflected the ratio of protein concentration in the whole RBCs
sample and the respective protein concentration in the
subsequent WG sample. MPE was computed for the 10 most
abundant integral membrane proteins (Table S2).
=Copy number Copy number i MPE( )/WG
Membrane proteins are often glycosylated with predominant
N-glycosylation. To assess whether the N-glycosylation has an
effect on the label free quantitation, we compared the proteins




In this study we analyzed RBC samples originating from four
donors (Figure 1). We analyzed whole cell lysates and
membrane fractions prepared by hypotonic lysis of RBCs,
resulting in WGs. Proteins were extracted with 2% SDS and
subjected to the filter-aided sample preparation (FASP)
approach, which allows unbiased analysis of soluble and
membrane proteins.20,25 To cover the highest number of
RBCs proteins and to achieve the height sequence coverage,
each protein extract was consecutively digested using two
enzymes. In the first cleavage step, endoproteinase Arg C,
GluC, or LysC was used. After elution and collection of
peptides, in the second step, the material remaining in the filter
was treated with trypsin (Figure 1B). Protein digestions were
carried out in the absence of any denaturant, a condition
ensuring high digestions yields with very low rates of peptides
with missed cleavage sites.20 Each peptide fraction was analyzed
separately by LC−MS/MS, and all recorded spectra were
searched together (Figure 1C). Each of the protein digestion
protocols resulted in a similar number of identified peptides per
analyzed sample of 2500−3000 in the analysis of the whole
RBCs and 6000−7000 peptides in the WG analysis (Figure
2A,B). The cumulative numbers of identified peptides per
sample were about 6000 and 15 000 for the whole cell and WG,
respectively. Comparing the three digestion strategies used, the
combination of LysC and trypsin enabled identification of the
highest number proteins; however, the two other enzyme
combinations significantly extended the total number of
identified proteins (Figure 2C−E). The total number of
proteins that were identified per donor sample matching
RBCs and WG analyses was about 2500 (Figure 2F, Table S3).
The Venn plots show that 30% of proteins were identified using
only one or two cleavage approaches (Figure 2G,H). This
result emphasizes the importance of multicleavage strategies for
comprehensive characterization of proteomes.26
RBC Purity
Purity of the RBCs samples is prerequisite for their unbiased
proteome analysis. In this study, we followed the efficient,
reproducible RBC processing protocol by Pesciotta et al.16
RBCs were stored for 24 h to reduce the number of
reticulocytes in 4 °C.
Next, RBCs were depleted of small cells, including platelets
and microparticles, by repeated sample washing and low-speed
centrifugation. Finally, leucocytes, neutrophils, and other cells
larger than RBCs were removed by filtration (Figure 1).
Because our analysis provided absolute abundance values of
proteins, we could estimate the extent of contamination of the
RBCs by platelets and leucocytes. In contrast with RBCs,
leucocytes and neutrophils are nucleated cells. Each nucleus of
a 2n human cell contains ∼2.7 × 108 copies of all core and
linker histones. We identified (1.5 to 7.0) × 104 histone
molecules across the samples (Table S3). This value accounts
for one leucocyte or neutrophil per 104 RBCs. Out of the
platelet-specific antigens such as CD36, CD41, CD42, and
CD61 occurring at 20−80 000 copies per platelet,27 we
identified only CD36 at a copy number of 64 ± 17. This
suggests a maximal platelet contamination below 1 platelet per
1000 erythrocytes. In fact, the contamination of our
preparations RBC and WG by platelets could be even lower.
Notably, we did not identify some of the top ten most
abundant platelet proteins such as platelet factor 4 or platelet
basic protein, which occur in these cells at 530 000 and 355 000
copies, respectively.27 Thus quantitative proteomics data
confirmed the expected depletion of leucocytes and platelets
from the RBC samples. Because a minute contamination of the
erythrocyte preparations by other blood cells cannot be avoided
we consider proteins above a threshold of 100 copies as those
occurring in erythrocytes. However, we do not rule out the
possibility that some proteins with abundances below this limit
may also originate from RBCs. In addition we cannot exclude
contamination of the RBC and their membrane preparations by
plasma proteins. For example, the most abundant plasma
protein, albumin, was present at several thousand copies.
To estimate contamination of the RBC preparation we
compared the abundances of ribosomal subunits that were
calculated in this study with abundances abundance of these
proteins in reticulocytes.28 In our preparation the median
abundance of these subunits was 200 copies per cell, whereas in
reticulocytes the corresponding value was 220 000. This
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suggests that RBC preparations used in our analyses were
contaminated by <0.1% reticulocytes
Protein Quantification
Across the preparations the MPE was in the range of 8−12
(Figure 3A). 1890 identified proteins occurred at >100 copies
per cell; 1536 identified in the whole cell lysate and 1406 found
in the WG fraction (Figure 3B). For the known RBC
membrane proteins we observed an excellent correlation
[r(Pearson) = 0.93] between copy numbers of proteins
calculated using data from both whole cells and WGs data
sets (Figure 3C). The analysis revealed that N-glycosylation has
practically no effect on protein quantification (Figure 3D).
Analysis of the Whole RBCs
Analysis of whole RBCs lysates allowed the identification of
2090 proteins. Of those, 450 were quantified across all samples
(Figure 3B). Hemoglobin is the dominant protein of the RBCs.
Its subunits alpha (HbA) and beta (HbB) exist at about 200
million copies, whereas the less abundant subunits delta (HbD)
and gamma (HbG) occur at about 30 and 4 million copies,
respectively (Figure 4A). Surprisingly, we also found significant
amounts of the subunits theta (HbQ) (400 000 copies), zeta
(HbZ) (900 000 copies), and mu (HbM) (100 000 copies);
these are generally considered to be embryonic forms of
hemoglobin. Identification of these isoforms in the presence of
>100-fold excess of HbA and HbB stresses the power of mass
spectrometry compared with classical biochemical methods.
Carbonic anhydrase is the second most abundant protein. Its
isoform 1 (CA1) is present at about 20 million copies.
Peroxiredoxin-1, -2, and -6 (PRDX1, PRDX12, and PRDX16)
occur with similar copy numbers. The next group of highly
abundant proteins consists of biliverdin reductase B (BLVRB),
which catalyzes reduction of methemoglobin, and catalase
(CAT) and superoxide desmutase (SOD1), which protect from
toxic effects of oxygen peroxide and radicals, respectively.
Bisphosphoglycerate mutase (BPGM), the central enzyme of
the Rapoport−Luebering cycle, is present at 1.6 million copies.
BPGM converts 1,3-bisphosphoglycerate, which is formed by
glycolysis, to 2,3-bisphosphoglycarate (2,3-BPG). The main
role of 2,3-BPG is to shift the equilibrium of hemoglobin
toward the deoxy state. Housekeeping enzymes glyceraldehyde-
P dehydrogenase (GAPDH) and deglycase (PARK7)29 are
present at 1.4 and 0.7 million copies, respectively. Calcium
binder S100A4 is present at about 2 million copies. Another
enzyme found to be present at 2−3 million copies was α-
synuclein. Notably, it has recently be reported that RBCs as the
major source of α-synuclein in blood.30
To compare abundance of proteins between RBCs and
nonerythroid cells, such as hepatocytes31 and cultured cells,31,32
we used protein concentrations, which are not affected by cell
size (Figure 4B). Hemoglobin subunits, CA1, SLC4A1, α-
synulcein, and BPGM exist in RBCs at concentration higher by
a least 1000 times compared with common cells. The
concentrations of proteins protecting from exposure to oxygen,
PRDX2, BLVRB, and CAT, are 100 times higher compared
with nonerythroid cells. Proteins with “housekeeping” functions
Figure 3. Quantitative analysis. (A) Average enrichment of top 10
most abundant membrane proteins in the WG fractions relative to
whole RBCs. (B) Distribution of protein copy numbers across all
proteins in whole cells (red circles) and WG fractions (blue circles).
The dashed line shows the 100 copy per cell sample purity threshold.
(C) Correlation of the copy numbers for the known plasma membrane
proteins calculated using data from analysis of whole cells and WG
fractions. (D) Correlation of assessed protein abundance with and
without protein deglycosylation.
Figure 4. Proteomics analysis of the whole RBCs. (A) Copy numbers
of the 20 most abundant proteins in RBCs. (B) Comparison of the
concentrations of the most abundant proteins in RBCs compared with
nonerythroid human cells. The values for the nonerythroid cells are
based on proteomics analyses of human hepatocytes31 and cultured
cells.31,32 (C) Total protein content of basic metabolic processes in
RBCs compared with the nonerythroid cells. The black bars show the
average value across different human cells. The gradient area of the
bars shows standard deviation.
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have similar concentrations in RBCs and nonerythroid cells.
Enzymes involved in the glycolytic and pentose phosphate
pathways constitute a similar portion of total protein of RBCs
compared with nonerythroid cells. In contrast fatty acid
synthase and enzymes of oxidative phosphorylation are present
at significantly lower amounts in RBCs. Notably, not all key
enzymes of the oxidative phosphorylation were identified,
indicating interruption of this process. In addition, we were
unsuccessful in identification of some of these proteins by
Western blotting (Figure S1). This suggests their occurrence in
a partially degraded state and most probably only in “young”
RBCs. Proteins originating from nucleus, mitochondria, and
other organelles identified in our and previous proteomics
RBCs studies10,15 were suggested by us and the previous
authors to represent nonfunctional remnants of erythrocyte
maturation.
Analysis of the WG Fraction: Identification of Novel
Membrane Proteins
Analysis of WG fractions resulted in the identification of 2400
proteins. The plasma membrane and cytoskeletal proteins
constitute the most abundant portion of total protein (Figure
5A). Approximately 20% of the total WG protein is predicted
to be integral to membranes. The WG is a crude membrane
preparation and hence contains a substantial proportion of
nonplasma membrane proteins. Cytosolic proteins contribute
in 20% of total protein to WG preparation, and more than 300
proteins have ER or Golgi “Gene Ontology” annotation. An
almost complete set of ribosomal and proteosomal proteins was
identified in this fraction.
For about 50 proteins of the WG fraction the copy numbers
have been reported in the past. We found that copy number
values calculated by the TPA approach were similar to the
literature data for most proteins (Table 1, Figure 5B). A
comparison of the data sets provides a Spearman correlation
coefficient r of 0.71. However, obvious discrepancies were
found for some proteins. The TPA-based copy number values
for STOM were about 2 orders of magnitude higher compared
with the literature data. In contrast, GYPA appeared to be 5−10
times less abundant compared with previous studies. Across
references the copy numbers of SLC2A1 vary between 200 000
and 700 000.33 To clarify these differences we have quantified
these proteins by means of a so-called “targeted approach”.
Two donor WG samples were spiked with stable isotope-
labeled peptide standards and were analyzed by LC−MS/MS.
The results confirmed the accuracy of the TPA quantification of
Figure 5. Composition of the WG preparation. (A) Global composition of WGs based on Gene Ontology (GO) annotations. In parentheses is the
total number of proteins per GO term. (B) Comparison of the protein copy numbers determined by total protein approach (TPA) with literature
values (Table 1). r, Spearman’s correlation coefficient. (C) Comparison of the copy numbers of Glycophorin A (GYPA), Glut1 (SLC2A1), and Band
7-Stomatin (STOM) determined by TPA and targeted analysis. Two donor samples were analyzed. (D) Copy numbers membrane transporter
proteins identified with >100 copies.
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STOM, GYPA, and SLC2A1 (Figure 5C), suggesting that some
older quantification data based on biochemical approaches
needs to be revised.
Membrane channels and transporters are essential for the
exchange of metabolites and ions between the cytoplasm and
the environment of the cell. Our analysis provides a
comprehensive picture of the occurrence of these proteins in
the RBCs membrane. 41 proteins of this class were identified at
more than 100 copies per cell (Figure 5D). The most abundant
one is the solute carrier family 4, member 1/band 3 anion
exchange protein (SLC4A1/AE1) present in >1 000 000 copies
per RBCs, whereas the glucose transporter SLC2A1 occurs at
about 200 000 copies. Proteins involved in transport of water,
urea, ammonia, nucleosides, calcium, and iron exist at 20 000−
60 000 copies. The Na+/K+ ATPase and the K+ channel
Gardos are present at 3000−5000 copies. Other transporter
proteins, often without known specificity, exist at fewer than
1000 copies. Some of these transporters, including the drug
transporter, ATP-binding-cassette (ABC) subfamily A, member
7 (ABCA7) and the choline transporters, solute carrier family
44, members 1 and 2 (SLC44A1 and SLC44A2), have not
previously been reported for RBCs.
In addition to the well known structural and transport
proteins of the plasma membrane, our analyses mapped many
other proteins with predicted transmembrane domains (Table
S3). For example, 16 proteins with names “Transmembrane
protein number” (TMEMnumber) and 7 “Transmembrane
emp24 domain-containing” proteins were found at 100−8000
copies. Most of these have not been functionally characterized.
■ DISCUSSION
Proteomics Analysis
To our knowledge, this study provides the most comprehensive
proteome analysis of the human erythrocyte so far. We provide
absolute protein abundance estimations in RBCs and their WG
fractions. To increase the depth of analysis and quantitation
accuracy we applied three different protein cleavage strategies
using the MED FASP format. We identified 2650 proteins,
among them 1890 proteins occurring at more than 100 copies
per cell. Notably, this study allowed identification of low
abundant membrane transporters and other membrane
proteins with unknown functions. Because our data are
quantitative, the created database can serve to the community
Table 1. Comparison of Protein Copy Numbers Obtained by the Proteomics Analysis and the Literature Dataa
protein gene copies (×10−3) literature copies ± st. dev (×10−3) proteomics
AE1 (band 3) SLC4A1 1200 1074 ± 114
b-Actin ACTB 500 908 ± 65
Stomatin (band 7) STOM 10 643 ± 79 (1100)b
b-Spectrin SPTB 242 612 ± 69
a-Spectrin SPTA1 242 590 ± 67
Glyceraldehyde-P DH GAPDH 500 475 ± 120
Ankyrin ANK1 124 479 ± 32
Protein 4.2 EPB42 250 411 ± 20
Protein 4.1 EPB41 200 350 ± 35
Tropomyosin TPM3 70 253 ± 66
b-Adducin ADD2 30 181 ± 14
p55 MPP1 80 181 ± 9.6
Tropomodulin TMOD1 30 184 ± 26
Glut1 SLC2A1 200−700 170 ± 18 (200)
Dematin (band 4.9) EPB49 140 153 ± 20
CD59 CD59 20−40 116 ± 39
a-Adducin ADD1 30 103 ± 5.1
Rh polypeptide RHCE, RHD 200 (D and CE) 63 ± 17
Glycophorin A GYPA 500−1000 96 ± 67 (52)
Aquaporin 1 AQP1 120−160 58 ± 10
Kell glycoprotein KEL 3−18 50 ± 5.4
CD47 CD47 10−50 47 ± 5.4
RhAG RHAG 100−200 53 ± 25
Nucleoside transporter SLC29A1 10 26 ± 4.2
LW glycoprotein ICAM4 3−5 21 ± 10
Urea transporter SLC14A1 14 26 ± 8.2
AChE ACHE 10 16 ± 2.9
Lutheran glycoprotein BCAM 1.5−4 16 ± 5.7
CD99 CD99 1 10 ± 2.6
CD58 (LFA-3) CD58 3−7 10 ± 0.9
KX XK 1.5−4 8.1 ± 3.2
CD44 CD44 6−10 6.6 ± 2.2
DAF (CD55) CD55 20 4.8 ± 2.6
Duffy FY 6−13 5.0 ± 2.5
CR1 CR1 0.02−1.5 0.6 ± 0.3
aFrom data compilation by Burton and Bruce.33 bIn parentheses are values that were assessed by targeted proteomics analysis.
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as a useful tool for further studies on RBCs diseases and
erythrocyte aging during storage in blood banks.34
Protein Copy Numbers
The composition of the plasma membrane of human RBCs has
been studied over the past several decades. Previously, copy
numbers of membrane proteins were determined by classical
and biochemical methods, such as radioimmunoassay6,7 and
densitometry of Coomassie-stained polyacrylamide gels.4
Because all of these methodologies allowed only indirect
measurements, the accuracy of the data appears to be moderate.
For instance, the copy numbers reported by Anstee et al. for
CD44 varied from 1888 to 10 ,450 between individual assays
and antibodies used.6 Relatively high copy numbers for GYPA
were derived from Scatchard plots,7 which are known to be
prone to generating large errors.35 Copy numbers assessed by
Coomassie staining4 are biased by uneven binding of the stain
to proteins varying in their amino acid composition. This
phenomenon was not taken into consideration. In addition,
many of these calculations assumed a standard protein content
of 0.6 pg per single WG, an estimate provided by Dodge et
al.,36 but overlooked the fact that the total membrane protein
content can vary between methods used for WG preparation.
Because quantitative analyses using only single enzymes for
protein digestion may be heavily biased against proteins lacking
specific cleavage sites, in this study we applied three different
protein digestion strategies. The protein abundance data
reported here were calculated by averaging the TPA values
obtained from the three different protein digests. In the present
study copy number values were computed using the TPA
approach. The copy numbers calculated by TPA showed
excellent correlation with the literature data.22 Accuracy of the
approach was validated by comparing with data from targeted
approaches37 and demonstrated that on average, the deviation
between values obtained by TPA and targeted proteomics was
1.5 fold. We provided a global proteome quantification; for
many proteins the abundance values reported here are only
estimates. Nonetheless the copy number values attained for the
RBCs membrane correlate well with the literature (Figure 5B).
Although for a few proteins, such as GYPA and STOM, the
TPA and previous reports were quite different, targeted analysis
showed that the values were close to the TPA copy number
estimates. Similarly, the TPA values for GLUT1 copy number
agreed well with the labeled standard-based quantification.
Membrane Transporters
Membrane transporters are of pivotal importance for cell
homeostasis and play a crucial role in diseases. This study is the
first to provide comprehensive and quantitative data set of
membrane transporter proteins in the RBCs membrane.
We identified eight members of the ABC transporters family
(ABCA7, ABCB6, ABCC1, ABCC4, ABCC5, ABCE1, ABCF1,
ABCG2). Some of them had already been identified in previous
nonproteomics studies.38 ABCB6 and ABCB10 were assigned
to mitochondria, although it has been recently shown that
ABCB6 is secreted in exosomes, and resides on the erythrocyte
cell surface.38 ABCB6 is functionally relevant in the plasma
membrane, where its expression prevents the accumulation of
specific porphyrins in the cell.39 We found ABCB6 at 10 000−
20 000 copies in RBCs, whereas in human hepatocytes and
cultured hepatoma cells this protein occurs at 50 000−75 000
copies.31 This three- to five-fold difference may be attributed to
the fact that due to their function the RBCs require an efficient
porphyrin clearance system.
The presence of human multidrug resistance protein 1
(MRP1/ABCC1) in the human erythrocyte membrane is well
established.40 Recently, the indirect evidence suggesting that
ABCC4 (MRP4) and ABCC5 (MRP5) contribute to cGMP
transport in RBCs was confirmed with a new inhibitor of
ABCC4 transport.41 In another study, immunoprecipitation of
ABCC5 from CHAPS-solubilized extracts reduced active
transport by ∼45%, showing that MRP5 is an important
cGMP-transporting protein in human erythrocytes.42 We
provided the first evidence of the presence of the ABCA7
transporter on the red blood cell membrane. The potential
roles of this protein, such as binding of APOA1 and
phospholipid efflux from cells,43 have to be further investigated
in the context of the red blood cell membrane.
Loss of some membrane surface results in hereditary
spherocytosis syndrome manifesting as hemolytic anemia,44
which may be attributed not only to the qualitative but also
quantitative changes of the RBC membrane proteins. For
example, absence of band 3 causes severe hereditary
spherocytosis,45 whereas a decrease in human erythroid protein
4.1R may result in hereditary elliptocytosis.46 SDS−polyacry-
lamide gel electrophoresis (PAGE) is the technique recom-
mended by the International Council for Standarization in
Haematology for the quantitation of relative membrane protein
contents in diseases such as hereditary elliptocytosis.47
Currently, there is an increasing need for a precise tool for
the detection of copy numbers of red blood cell membrane
proteins, also in relation to such diseases as Alzheimer’s disease
or cancer. Data obtained by flow cytometry indicate that in late
onset Alzheimer disease, the GLUT1, ABCA1, and the ABCG2
transporters are significantly increased in comparison with age-
matched control subjects.48 Because ABCG2 polymorphisms
are known to modify essential pharmacokinetic parameters, uric
acid metabolism, and cancer drug resistance, a direct
determination of the erythrocyte membrane ABCG2 protein
expression may provide valuable information for assessing these
conditions or for devising drug treatments.49
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